EUVIMEDEUVIMED entdecken
Crossref

Bile acid receptor FXR promotes intestinal epithelial ferroptosis and subsequent ILC3 dysfunction in neonatal necrotizing enterocolitis

Yuxin Zhang, Yuchao Jing, Juan He, Rui Dong, Tongyang Li, Fang Li, Xiaoqing Zheng, Gaoyu Liu, Ran Jia, Jin Xu, Fan Wu, Chunhong Jia und 8 weitere

Immunity · 2025

DOI: 10.1016/j.immuni.2025.02.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2025. Verfasst von Yuxin Zhang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Institute of Immunology, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Key Laboratory of Immune Mic…. Hauptthemen laut MEDLINE: Ferroptosis, Enterocolitis, Necrotizing, Receptors, Cytoplasmic and Nuclear, Intestinal Mucosa. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 89 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Necrotizing enterocolitis (NEC) is a common pediatric emergency primarily afflicting preterm infants, yet its mechanisms remain to be fully understood. Here, we report that plasma fibroblast growth factor (FGF)19, a target of farnesoid X receptor (FXR), was positively correlated with the clinical parameters of NEC. NEC patients and the NEC murine model displayed abundant FXR in intestinal epithelial cells (IECs), which was restricted by microbiota-derived short-chain fatty acids (SCFAs) under homeostasis. Genetic deficiency of FXR in IECs caused remission of NEC. Mechanistically, FXR facilitated ferroptosis of IECs via targeting acyl-coenzyme A synthetase long-chain family member 4 (Acsl4). Lipid peroxides released by ferroptotic IECs suppressed interleukin (IL)-22 secretion from type 3 innate lymphoid cells (ILC3s), thereby exacerbating NEC. Intestinal FXR antagonist, ACSL4 inhibitor, and ferroptosis inhibitor ameliorated murine NEC. Furthermore, the elevated lipid peroxides in NEC patients were positively correlated with FGF19 and disease parameters. These observations demonstrate the therapeutic value of targeting intestinal FXR and ferroptosis in NEC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisEnterocolitis, NecrotizingReceptors, Cytoplasmic and NuclearIntestinal MucosaLymphocytesAnimalsHumansMiceInfant, NewbornFibroblast Growth FactorsDisease Models, AnimalMice, Inbred C57BLCoenzyme A LigasesMice, KnockoutFemaleMaleImmunity, InnateReceptor, Farnesoid X-Activated

Stichwörter der Autor:innen

FXRIECsILC3sNECmicrobiotaneonatal intestine

Substanzen

Receptors, Cytoplasmic and NuclearFibroblast Growth FactorsCoenzyme A LigasesReceptor, Farnesoid X-ActivatedFGF19 protein, humanAcsl4 protein, mouse

Autor:innen und Institutionen

  • Tianjin Institute of Immunology, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Mi…
  • Provincial Key Laboratory of Research in Structure Birth Defect Disease and Department of Pediatric Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China.
  • Department of Central Laboratory, Changzhi Medical College, Changzhi 046000, China.
  • Laboratory of Immunity, Inflammation & Cancer, Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
  • Department of Clinical Laboratory, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China.
  • Department of Neonatology, Guangzhou Key Laboratory of Neonatal Intestinal Diseases, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, Guangdong, China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Y., Jing, Y., He, J., Dong, R., Li, T., Li, F., Zheng, X., Liu, G., Jia, R., Xu, J., Wu, F., Jia, C., Song, J., Zhang, L., Zhou, P., Wang, H., Yao, Z., Liu, Q., Yu, Y., & Zhou, J. (2025). Bile acid receptor FXR promotes intestinal epithelial ferroptosis and subsequent ILC3 dysfunction in neonatal necrotizing enterocolitis. Immunity. https://doi.org/10.1016/j.immuni.2025.02.003

Vancouver

Zhang Y, Jing Y, He J, Dong R, Li T, Li F, et al. Bile acid receptor FXR promotes intestinal epithelial ferroptosis and subsequent ILC3 dysfunction in neonatal necrotizing enterocolitis. Immunity. 2025. doi:10.1016/j.immuni.2025.02.003

BibTeX
@article{Zhang2025,
  author = {Zhang, Yuxin and Jing, Yuchao and He, Juan and Dong, Rui and Li, Tongyang and Li, Fang and Zheng, Xiaoqing and Liu, Gaoyu and Jia, Ran and Xu, Jin and Wu, Fan and Jia, Chunhong and Song, Jin and Zhang, Lijuan and Zhou, Pan and Wang, Haitao and Yao, Zhi and Liu, Qiang and Yu, Ying and Zhou, Jie},
  title = {Bile acid receptor FXR promotes intestinal epithelial ferroptosis and subsequent ILC3 dysfunction in neonatal necrotizing enterocolitis},
  journal = {Immunity},
  year = {2025},
  doi = {10.1016/j.immuni.2025.02.003}
}
Kostenlos starten →